the distribution of each white blood cell subset and its immune-endocrine regulatory mechanism. The distribution of each lymphocyte and granulocyte subset is essential for the immune responses, because the continuous migration of immune cells ensures the detection of antigens and neoplasms, and promotes cellular interactions that enable the immune system to execute rapid and effective responses (13) (14) (15) . Furthermore, the distribution of WBCs is regulated by adrenal glucocorticoids (16) . Therefore, we examined the dose-dependent effects of DADS administration on the circulating number of WBCs, such as lymphocytes (T-lymphocytes, B-lymphocytes, and natural killer (NK) cells), granulocytes (neutrophils, eosinophils, and basophils) and monocytes, and plasma corticosterone concentration in rats.
Materials and Methods
Experimental procedure and animal care. The experimental protocol used in the present study is shown in Fig. 1 . Male 10-wk-old Sprague Dawley rats (CLEA Japan, Inc., Tokyo, Japan) were pre-fed for 3 d to allow adaptation to a new environment. All rats were housed in stainless steel cages at a controlled temperature (23-25˚C) and relative humidity (50-60%). Lighting was automatically provided from 8:30-20:30. Animal chow (CE-2 cubic type, CLEA Japan, Inc.) and distilled water were given to the rats ad libitum (17) . After the adaptation period, the rats were randomly divided into the DADS-free and DADS-orally administered (doseϭ10, 20, and 40 mg/kg BW) groups (nϭ8-9/group).
The present study (2011-A093) was approved by the Animal Ethics Committee, Waseda University, and conducted according to the Guiding Principles for the Care and Use of Animals in the Field of Physiological Sciences, the Physiological Society of Japan (18) . The experiment was performed with the least possible pain or discomfort to rats.
Oral administration of DADS. DADS (99.5% purity, LKT Lab, Inc., St Paul, MN, USA) was dissolved in 2% ethanol, and then supplemented with 0.9% NaCl solu-tion containing 10% Tween 80 as a vehicle to obtain 0.5, 1.0, and 2.0% DADS solution. Then, 0.5, 1.0, and 2.0% DADS solution were administered orally as the dosage of 10, 20, and 40 mg/kg BW to DADS-orally administered rats, respectively. The dosage of DADS was used according to the report of Munday and Munday (19) . An equivalent volume of the vehicle was administered to the DADS-free rats instead of DADS solution in the same manner.
Blood sampling. As shown in Fig. 1 , a whole blood sample was collected with a heparinized microcapillary tube from the tail vein at 0, 1, 2, 4, and 6 h after the administration. Plasma was obtained by centrifugation of the whole blood sample with 3,000 ϫg for 5 min at 4˚C, and the plasma sample was stored at Ϫ80˚C until assay (20) .
Count analyses of WBCs. Fifty microliters of the whole blood sample was immediately prepared with a microsyringe and diluted by 20% with cellpack, a whole blood diluent for use in a hematology analyzer (Sysmex Co., Hyogo, Japan) (15) , and then the number of WBCs (total WBCs, total lymphocytes, monocytes, neutrophils, eosinophils, and basophils) was analyzed by a hematology analyzer (Model SF-3000, Sysmex Co.) based on a fl ow-cytometry technique with a light-emitting diode (15) .
Count analyses of lymphocyte subsets. After 4 h from the administration of DADS, the number of T-lymphocytes, B-lymphocytes, and NK cells were determined by a direct immunofl uorescent staining with a fl owcytometric analysis according to our routine methods (20) . We used the IOTest Anti-Rat CD3-FITC/CD45RA-PC7/CD161a-APC (Beckman Coulter, Brea, CA, USA). Twenty fi ve microliters of the whole blood sample was incubated with 25 L of the primary antibody for 20 min at room temperature in the dark. Then, 1 mL of BD FACS lysing solution (Becton Dickinson, Franklin Lakes, NJ, USA) was added to the sample, and incubated for 5 min. After the centrifugation at 1,500 ϫg for 3 min at 4˚C, the supernatant was discarded and replaced with 1 mL of phosphate-buffered saline (PBS, pH 7.4). After the fi ltration with Cell Strainer (a strong nylon mesh with 40 micron pores, Becton Dickinson), the cells were analyzed using FACS Calibur (Becton Dickinson).
Assay of plasma corticosterone concentration. Plasma corticosterone concentra tion was assessed using an enzyme-linked immunosorbent assay (ELISA) (YK 240 Corticosterone EIA, Yanaihara Institute Inc., Shizuoka, Japan) (20) .
Statistical analyses. All data are presented as means Ϯstandard error of the mean (SE). The effects of DADS administration on the circulating number of WBCs were analyzed by two-way ANOVA for repeated measures, and then estimated using Tukey-Kramer multiple comparison tests. The effects of DADS administration on the circulating number of lymphocyte subsets and plasma corticosterone concentration were analyzed by one-way ANOVA, and then estimated using Tukey-Kramer multiple comparison tests. Differences were considered signifi cant when p was Ͻ0.05. 
Results

Dose-dependent effects of DADS administration on the number of WBCs
When 20 and 40 mg/kg BW of DADS were orally administered to rats, the circulating number of total WBCs, total lymphocytes, and monocytes was gradually reduced along with the time course as compared with the values in the DADS-free rats, and the differences between the DADS-administered groups and the DADSfree group become statistically signifi cant from 4 h after the administration (Fig. 2 ). In addition, dose-dependency of DADS administration effects was observed in the doses of 20 and 40 mg/kg BW but not in the dose of 10 mg/kg BW (Fig. 2) . On the other hand, although the circulating number of neutrophils was not signifi cantly changed by the administration of the different doses of DADS, the circulating number of eosinophils and basophils showed a decreasing tendency after DADS administration (Fig. 2) .
Dose-dependent effects of DADS administration on the number of lymphocyte subsets
As shown in Fig. 3 , when 20 and 40 mg/kg BW of DADS were orally administered to rats, the circulating number of T-lymphocytes and B-lymphocytes was dose-dependently reduced 4 h after the administration, although such effects were not affected by the administration of 10 mg/kg BW of DADS. On the other hand, the circulating number of NK cells was not affected by the administration of the different doses of DADS (Fig.  3) . 
Dose-dependent effects of DADS administration on plasma corticosterone concentration
When 20 and 40 mg/kg BW of DADS were orally administered to rats, the plasma concentration of corticosterone was dose-dependently increased 2 h after the administration, but not affected by the administration of 10 mg/kg BW of DADS (Fig. 4) . These results indicate that the circulating number of T-lymphocytes, B-lymphocytes, and monocytes, and plasma corticosterone concentration were inversely changed in response to DADS administration.
Discussion
DADS, a pungent compound of garlic, binds to and activates transient receptor potential ankyrin 1 (TRPA1) and transient receptor potential vanilloid 1 (TRPV1) (21, 22) . These ionic channels are expressed in skin and primary sensory neurons. Activation of TRPA1 and TRPV1 in sensory neuro-fi bers leads to noradrenalin and adrenalin secretions (23, 24) . In fact, Oi et al. (25) demonstrated that DADS administration to rats results in noradrenalin and adrenalin secretions. On the other hand, such sympathetic nervous activations stimulate the hypothalamus-pituitary-adrenal (HPA) axis, and this leads to release of glucocorticoids from the adrenal cortex. Actually, we demonstrated that DADS administration increased dose-dependently plasma corticosterone concentration 2 h after the administration (Fig. 4 ).
Dhabhar and Mcewen (26, 27) showed that glucocorticoids promote adhesion between endothelial cells and leukocytes, including lymphocytes and monocytes, and migration of these immune cells from the blood fl ow to some marginal spaces, such as the skin, lung, gastrointestinal tract, mucosal surface, and lymph nodes. Thus, increased plasma glucocorticoid levels cause a significant reduction in the circulating number of lymphocytes and monocytes (26) . In fact, acute administration of corticosterone and dexamethasone reduced the circulating number of these cells (16, 28) . Furthermore, glucocorticoids are known to act more sensitively to B-lymphocytes than T-lymphocytes and NK cells (26) .
Indeed, we also demonstrated that DADS administra-tion decreased dose-and time-dependently the circulating number of total lymphocytes and monocytes. In addition, DADS administration reduced dose-dependently the circulating number of T-lymphocytes and B-lymphocytes without changing that of NK cells 4 h after the administration (Figs. 2 and 3) , and the reduction rate of the circulating number of B-lymphocytes was higher than that of T-lymphocytes (Fig. 3) . These results suggest that DADS administration stimulated corticosterone secretion via the activation of the HPA axis, resulting in reduction of the circulating number of T-lymphocytes, B-lymphocytes, and monocytes. By contrast, an in vitro study by Liu et al. (29) revealed that there were no adverse effects on the growth of the macrophage cell line RAW264.7 when the cells were treated with 400 M DADS; there is no report addressing cytotoxic effects of DADS toward a variety of white blood cells. Thus, it cannot be denied that the decreased number of lymphocytes and monocytes in blood was caused by direct cytotoxic effects of DADS.
Furthermore, it was reported that a portion of DADS reacts with amino acid cysteine to form S-allylmercaptocysteine in the digestive tract (30) . DADS is also partially converted to allyl mercaptan in the blood before reaching the liver or other organs, and is transformed into other products including allyl methyl sulfi de, allyl methyl sulfoxide and allyl methyl sulfone (30) (31) (32) . Thus, it is conceivable that these metabolic products affect the number of lymphocytes and monocytes. Therefore it is necessary to investigate these unknown points in a future study.
On the other hand, DADS administration did not affect the circulating number of neutrophils ( Fig. 2 ), suggesting that DADS administration-induced corticosterone was not enough to recruit neutrophils from the bone marrow pool to the circulation. However, the number of eosinophils and basophils showed a decreasing tendency after DADS administration. Therefore, it is necessary to investigate how the number of eosinophils and basophils is changed after 8 h from DADS administration in a future study.
In conclusion, DADS administration reduces the circulating number of monocytes and lymphocytes, including especially acquired immune cells, via the action of corticosterone, and the effects are induced in a dose-dependent manner. 
